Detalles de la búsqueda
1.
A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach.
Proteome Sci
; 20(1): 9, 2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578244
2.
Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses.
J Vet Sci
; 24(5): e67, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031646
3.
Identification of the Brucea javanica Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay.
ACS Omega
; 8(31): 28543-28552, 2023 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37576644
4.
Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines.
Curr Res Pharmacol Drug Discov
; 3: 100132, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36568260
5.
Siamenflavones A-C, three undescribed biflavonoids from Selaginella siamensis Hieron. and biflavonoids from spike mosses as EGFR inhibitor.
Phytochemistry
; 203: 113374, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964804
6.
Generation of a nanobody against HER2 tyrosine kinase using phage display library screening for HER2-positive breast cancer therapy development.
Protein Eng Des Sel
; 342021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34908139
Resultados
1 -
6
de 6
1
Próxima >
>>